The literature shows that prolactinomas are the most prevalent in the context of MEN1 (~65%), followed by somatotropinoma, ACTH-secreting adenoma, and non-functioning adenomas (21, 25). The gene discussed is MEN1; the disease is growth hormone-producing pituitary gland neoplasm.